In this context, S100A4 is another Ca2+-binding protein of significant importance in metastasizing tumors and is generally considered as biomarker for the tumor progression (Ismail et al. 2008, 2010; Bresnick et al. 2015). Here, S100A4 is linked to neoplasm.